CoChat

Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial

Xu, Shiling, Zeng, Weilin, Ngassa Mbenda, Huguette Gaelle, Liu, Huaie, Chen, Xi, Xiang, Zheng, Li, Cuiying, Zhang, Yanmei, Baird, J. Kevin, Yang, Zhaoqing, Cui, Liwang · 2020 · Travel Medicine and Infectious Disease
Cited by 25

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tmaid.2019.101499

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 29

  1. Baird, 2017, Asia-Pacific malaria is singular, pervasive, diverse and invisible, Int J Parasitol, 47, 371, 10.1016/j.ijpara.2016.06.006 · DOI
  2. Howes, 2016, Global epidemiology of plasmodium vivax, Am J Trop Med Hyg, 95, 15, 10.4269/ajtmh.16-0141 · DOI · Paper page
  3. Baird, 2009, Resistance to therapies for infection by Plasmodium vivax, Clin Microbiol Rev, 22, 508, 10.1128/CMR.00008-09 · DOI · Paper page
  4. Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
  5. Takala-Harrison, 2015, Antimalarial drug resistance in Africa: key lessons for the future, Ann N Y Acad Sci, 1342, 62, 10.1111/nyas.12766 · DOI
  6. Schuurkamp, 1992, Chloroquine-resistant plasmodium vivax in Papua New Guinea, Trans R Soc Trop Med Hyg, 86, 121, 10.1016/0035-9203(92)90531-G · DOI · Paper page
  7. Guthmann, 2008, Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar, Trop Med Int Health, 13, 91, 10.1111/j.1365-3156.2007.01978.x · DOI
  8. Yohannes, 2011, Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia, Am J Trop Med Hyg, 84, 137, 10.4269/ajtmh.2011.09-0723 · doi:10.4269/ajtmh.2011.09-0723
  9. Thanh, 2015, Confirmed plasmodium vivax resistance to chloroquine in central Vietnam, Antimicrob Agents Chemother, 59, 7411, 10.1128/AAC.00791-15 · DOI
  10. Saravu, 2016, Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of plasmodium vivax malaria from primary care centres in Southwestern India, PLoS One, 11, e0157666, 10.1371/journal.pone.0157666 · DOI · Paper page
  11. Wangchuk, 2016, Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan, Malar J, 15, 277, 10.1186/s12936-016-1320-8 · DOI
  12. Chu, 2018, Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria, Clin Infect Dis, 67, 1543, 10.1093/cid/ciy319 · DOI · Paper page
  13. Delacollette, 2009, Malaria trends and challenges in the greater Mekong subregion, Southeast Asian J Trop Med Public Health, 40, 674
  14. Liu, 2014, Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013, Malar J, 13, 364, 10.1186/1475-2875-13-364 · DOI
  15. Myat Phone, 1993, Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma), Trans R Soc Trop Med Hyg, 87, 687, 10.1016/0035-9203(93)90294-Z · DOI
  16. Marlar, 1995, Development of resistance to chloroquine by Plasmodium vivax in Myanmar, Trans R Soc Trop Med Hyg, 89, 307, 10.1016/0035-9203(95)90556-1 · DOI
  17. Yuan, 2015, Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar, Antimicrob Agents Chemother, 59, 1230, 10.1128/AAC.04270-14 · DOI · Paper page
  18. Htun, 2017, Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow, Malar J, 16, 281, 10.1186/s12936-017-1912-y · DOI
  19. Zhou, 2016, Impact of interventions on malaria in internally displaced persons along the China-Myanmar border: 2011-2014, Malar J, 15, 471, 10.1186/s12936-016-1512-2 · DOI
  20. Li, 2016, Plasmodium malariae and Plasmodium ovale infections in the China-Myanmar border area, Malar J, 15, 557, 10.1186/s12936-016-1605-y · DOI
  21. Liu, 2016, A more appropriate white blood cell count for estimating malaria parasite density in Plasmodium vivax patients in northeastern Myanmar, Acta Trop, 156, 152, 10.1016/j.actatropica.2016.01.018 · DOI
  22. Singh, 1999, A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies, Am J Trop Med Hyg, 60, 687, 10.4269/ajtmh.1999.60.687 · DOI · Paper page
  23. Leclerc, 2005, Genetic diversity of merozoite surface protein-1 gene of Plasmodium vivax isolates in mining villages of Venezuela (Bolivar State), Acta Trop, 95, 26, 10.1016/j.actatropica.2005.03.007 · DOI
  24. Baird, 1997, Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels, Am J Trop Med Hyg, 56, 621, 10.4269/ajtmh.1997.56.621 · DOI · Paper page
  25. Lin, 2015, Using amplicon deep sequencing to detect genetic signatures of plasmodium vivax relapse, J Infect Dis, 212, 999, 10.1093/infdis/jiv142 · DOI
  26. Zhong, 2018, Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa, Malar J, 17, 185, 10.1186/s12936-018-2337-y · DOI
  27. Pukrittayakamee, 2000, Therapeutic responses to different antimalarial drugs in vivax malaria, Antimicrob Agents Chemother, 44, 1680, 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
  28. Maneeboonyang, 2011, Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border, Southeast Asian J Trop Med Public Health, 42, 9
  29. Hanscheid, 2018, How "resistant" is artemisinin resistant malaria? - the risks of ambiguity using the term "resistant" malaria, Trav Med Infect Dis, 24, 23, 10.1016/j.tmaid.2018.04.008 · DOI

Cited by

See all 25

Metadata

Authors
Xu, S., Zeng, W., Ngassa Mbenda, H. G., Liu, H., Chen, X., Xiang, Z., Li, C., Zhang, Y., Baird, J. K., Yang, Z., & Cui, L.
Venue
Travel Medicine and Infectious Disease
Publisher
Elsevier BV
Published
2020-07
Volume
36
Pages
101499
ISSN
1477-8939
Cited by
25
References
1
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Natural Science Foundation of China
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial. https://app.cochat.ai/papers/10.1016/j.tmaid.2019.101499
The paper
Xu, S., Zeng, W., Ngassa Mbenda, H. G., Liu, H., Chen, X., Xiang, Z., Li, C., Zhang, Y., Baird, J. K., Yang, Z., & Cui, L. (2020). Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial. Travel Medicine and Infectious Disease. https://doi.org/10.1016/j.tmaid.2019.101499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.